Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN)

Autor:	Billie-Jo Hardy, Béatrice Séguin, Abdallah S. Daar, Peter Singer
Rok vydání:	2008
Předmět:	Economic growth medicine.medical_specialty education.field_of_study Government Public health genomics Resource (biology) Public health Population Developing country Genomics Biology Environmental protection Genetics medicine education Emerging markets Molecular Biology Genetics (clinical)
Zdroj:	Nature Reviews Genetics. 9:S5-S9
ISSN:	1471-0064 1471-0056
DOI:	10.1038/nrg2442
Popis:	In 2004, the government of Mexico established the National Institute of Genomic Medicine (INMEGEN), to carry out disease-related genomic studies that will address national health problems and stimulate scientific and technological development by generating new commercial products and services in genomic medicine. Towards this end, INMEGEN is carrying out a large-scale genotyping project to map genomic variation within its own population. The initiative is expected to generate a key resource for local researchers to understand disease susceptibility and variation in drug responses, which will contribute to Mexico's goal of developing public health genomics — a field in which Mexico is proving to be a leader amongst emerging economies.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f68f1f7f6244e83c62b6f2adc513eafe https://doi.org/10.1038/nrg2442 Zobrazit plný text záznamu